ISPC 8-K 2026-11-05

iSpecimen Inc. (ISPC) 8-K dated 2026-11-05 — accession 0001213900-26-116431.

iSpecimen Inc. (ISPC) is a diagnostics & research company listed on US.

iSpecimen Inc. filed a 8-K on 2026-11-05. Accession 0001213900-26-116431.

This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), Unregistered share sale (Item 3.02), Change in control (Item 5.01), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported ISPC revenue for 2025-12-31 was $1.9M. Net income was -$10.5M. Revenue was down 79.2% from 2024-12-31 to 2025-12-31. ISPC currently screens at market cap $4.4M.

Not investment advice. The ISPC SEC hub lists recent forms. The stock page is the research view.